Challenger Limited

CGF

AU000000CGF5

Life & Health Insurance

Market Closed - Australian S.E. Other stock markets 02:10:43 2024-04-26 am EDT			5-day change	1st Jan Change
6.71 ^AUD	-1.90%		+0.90%	+3.39%

Apr. 18	Challenger's Assets Under Management Rise 6% in Fiscal Q3; Upgrades Guidance	MT
Apr. 08	New Zealand Shares Decline on Monday; Heartland Group Secures Regulatory Approvals to Acquire Challenger Bank	MT

Challenger Limited Appoints Nicolas Hamilton as Director

January 03, 2022 at 05:59 pm EST

Challenger Limited announced the appointment of Nicolas Hamilton as director of the company. Date of appointment is 1 January 2022.

Latest news about Challenger Limited

Challenger's Assets Under Management Rise 6% in Fiscal Q3; Upgrades Guidance	Apr. 18	MT
New Zealand Shares Decline on Monday; Heartland Group Secures Regulatory Approvals to Acquire Challenger Bank	Apr. 08	MT
Heartland Group Receives Regulatory Approvals for Challenger Bank Acquisition; Begins NZ$210 Million Raise	Apr. 07	MT
Jarden Research Adjusts Challenger Limited’s Price Target to AU$7.55 From AU$7.25, Keeps at Overweight	Feb. 13	MT
Transcript : Challenger Limited, H1 2024 Earnings Call, Feb 13, 2024	Feb. 12
Challenger Posts 80% Jump in Fiscal H1 Net Profit	Feb. 12	MT
Challenger Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 12	CI
Challenger Limited Declares Interim Dividend for the Six Months Ended 31 December 2023, Payable on 19 March 2024	Feb. 12	CI
Transcript : Challenger Limited - Special Call	Nov. 30
Challenger Limited Announces Quarterly Dividend of One Quarter Ended February 25, 2024, Payable on February 26, 2024	Nov. 29	CI
Challenger Limited Announces Quarterly Dividend Ended February 26, 2024, Payable on February 25, 2024	Nov. 29	CI
Challenger Expands Relationship with Apollo Global Management	Nov. 09	MT
Challenger Limited Appoints Matthew Michelini as Director	Nov. 08	CI
Challenger Limited and Challenger Life Company Limited Announce the Appointment of Lisa Gray as Independent Non-Executive Director, Effective 9 November 2023	Nov. 08	CI
Transcript : Challenger Limited - Shareholder/Analyst Call	23-10-25
Challenger Limited Announces Board Changes	23-09-26	CI
Challenger Limited Declares Ordinary Dividend for the Six Months Period Ended 30 June 2023, Payable on 20 September 2023	23-09-14	CI
Challenger Raises Final Dividend as Fiscal 2023 Profit Grows; Shares Fall 6%	23-08-14	MT
Transcript : Challenger Limited, 2023 Earnings Call, Aug 15, 2023	23-08-14
Challenger Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-14	CI
Challenger Limited Declares Dividend for the Six Months Period Ended 30 June 2023, Payable on September 20, 2023	23-08-14	CI
Challenger to Provide De-Risking Service for Aware Super's Fund	23-07-26	MT
Challenger Completes Sale of Australian Real Estate Business	23-07-07	MT
Elanor Investors Limited and Elanor Investment Fund completed the acquisition of Challenger Real Estate from Challenger Limited.	23-07-06	CI
Pacific Current Group Sells Investment in Proterra Investment Partners Asia to Challenger Funds Management	23-06-22	MT

Challenger Limited is an Australia-based investment management company. The Company operates through two segments: Life and Funds Management. The Life segment principally includes the annuity and life insurance business carried out by Challenger Life Company (CLC). CLC offers fixed-rate and other retirement and superannuation products that are designed for Australian investors who are seeking a low-risk, fixed-term, or lifetime investment and reliable income. CLC also offers fixed-term and lifetime investments to investors in Japan through its reinsurance arrangement with Mitsui Sumitomo Primary Life Insurance Company Limited (MS Primary). CLC invests in assets that provide long-term income streams for customers. Its Funds Management segment is engaged in providing an end-to-end fund management business. The Funds Management segment also offers a range of managed investments across fixed income and property.

Sector

Life & Health Insurance

Calendar

2024-08-12 - Q4 2024 Earnings Release

Related indices

S&P/ASX 200

More about the company

Income Statement Evolution

More financial data

Ratings for Challenger Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

6.71 AUD

Average target price

7.548 AUD

Spread / Average Target

+12.50%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Life Insurance

	1st Jan change	Capi.
CHALLENGER LIMITED	+3.39%	3.05B
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD.	+3.05%	93.95B
CHINA LIFE INSURANCE COMPANY LIMITED	+1.78%	93.15B
LIFE INSURANCE CORPORATION OF INDIA	+18.68%	74.75B
AIA GROUP LIMITED	-20.65%	73.73B
CHINA PACIFIC INSURANCE (GROUP) CO., LTD.	+6.69%	29.69B
JAPAN POST HOLDINGS CO., LTD.	+18.06%	28.26B
FUBON FINANCIAL HOLDING CO., LTD.	+4.32%	26.51B
SBI LIFE INSURANCE COMPANY LIMITED	-1.21%	17.36B
HDFC LIFE INSURANCE COMPANY LIMITED	-9.10%	15.35B

Life Insurance